Company news

Bionano Genomics, Inc. news in 2026

Bionano Genomics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Bionano to Report Third Quarter 2026 Financial Results and Host a Conference Call Webcast on November 10, 2026

October 27, 2026

Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies

September 23, 2026

Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia

September 14, 2026

Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms

September 10, 2026

Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping

September 8, 2026

Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

August 24, 2026

Bionano Reports Second Quarter 2026 Results and Provides a Business Update

August 10, 2026

Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026

July 27, 2026

Bionano Announces Hiring of Chief Scientific Officer

June 24, 2026

Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption

June 18, 2026

Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders

June 11, 2026

Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures

May 27, 2026

Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia

May 26, 2026

Bionano Reports First Quarter 2026 Results and Provides a Business Update

May 13, 2026

Bionano Announces Leadership Transition

May 6, 2026

Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025

May 5, 2026

Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026

April 29, 2026

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma

April 1, 2026

Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026

March 23, 2026

Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting

March 16, 2026

Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026

March 9, 2026

Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale

February 27, 2026

10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders

February 26, 2026

11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy

February 25, 2026

9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies

February 24, 2026

Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping

February 9, 2026

Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies

February 4, 2026

Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results

January 12, 2026

Calls in 2026

Decks in 2026